BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28437537)

  • 1. Recent Patterns of Prostate-Specific Antigen Testing for Prostate Cancer Screening in the United States.
    Fedewa SA; Ward EM; Brawley O; Jemal A
    JAMA Intern Med; 2017 Jul; 177(7):1040-1042. PubMed ID: 28437537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Navigating Prostate Cancer Screening in the Real World of Primary Care: The Mirage and the Quicksand.
    Mathew P; Hachem H; Han P
    JAMA Oncol; 2018 Apr; 4(4):453-454. PubMed ID: 29470576
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening.
    Joshi SS; Filson CP
    Cancer; 2020 Feb; 126(4):694-696. PubMed ID: 31794066
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US guideline may have led to drop in PSA testing among primary care physicians, studies find.
    McCarthy M
    BMJ; 2015 May; 350():h2906. PubMed ID: 26021822
    [No Abstract]   [Full Text] [Related]  

  • 6. Relevance of total PSA and free PSA prescriptions.
    Lamy PJ; Brouillet JP; Bermont L; Fouillet G; Loric S
    Ann Biol Clin (Paris); 2018 Dec; 76(6):659-663. PubMed ID: 30543191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do men with lower urinary tract symptoms have an increased risk of advanced prostate cancer?
    Østerø Í Jákupsstovu J; Brodersen J
    BMJ; 2018 May; 361():k1202. PubMed ID: 29724877
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate cancer screening in New Zealand.
    Gray B
    N Z Med J; 2013 Sep; 126(1383):94. PubMed ID: 24157998
    [No Abstract]   [Full Text] [Related]  

  • 9. Revisiting Prostate Cancer Screening Practices Among Vermont Primary Care Physicians.
    Donnelly L; Sternberg KM; Ashikaga T; Plante MK; Perrapato SD
    J Community Health; 2018 Feb; 43(1):33-37. PubMed ID: 28620736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving detection and treatment methods change approaches to prostate cancer: US Preventive Services Task Force draft recommendations now align more closely with others.
    Printz C
    Cancer; 2018 Jan; 124(1):11-12. PubMed ID: 29251768
    [No Abstract]   [Full Text] [Related]  

  • 11. Educational Material on Prostate Cancer Screening is Overly Complex and Fails to Meet Recommended Layperson Readability Guidelines.
    Rooney MK; Morgans AK; Chen RC; Golden DW; Meeks JJ; Auffenberg G; Kundu SD; Schaeffer EM; Hussain MH; Kalapurakal JA; Sachdev S
    Urology; 2020 Jan; 135():1-3. PubMed ID: 31669135
    [No Abstract]   [Full Text] [Related]  

  • 12. Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care Physicians Following the 2012 USPSTF Recommendations.
    Zavaski ME; Meyer CP; Sammon JD; Hanske J; Gupta S; Sun M; Trinh QD
    JAMA Intern Med; 2016 Apr; 176(4):546-7. PubMed ID: 26857148
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of Prostate-Specific Antigen Testing Is in the Eye of the Beholder.
    Aaronson DS; Redberg RF
    JAMA Intern Med; 2016 Apr; 176(4):547-8. PubMed ID: 26856746
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].
    Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F;
    Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.
    Tikkinen KAO; Dahm P; Lytvyn L; Heen AF; Vernooij RWM; Siemieniuk RAC; Wheeler R; Vaughan B; Fobuzi AC; Blanker MH; Junod N; Sommer J; Stirnemann J; Yoshimura M; Auer R; MacDonald H; Guyatt G; Vandvik PO; Agoritsas T
    BMJ; 2018 Sep; 362():k3581. PubMed ID: 30185545
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prostate Specific Antigen (PSA), yet how much damage?].
    Braillon A; Hill C; Dubois G
    Presse Med; 2012 May; 41(5):482-5. PubMed ID: 22336482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary care physicians' use of an informed decision-making process for prostate cancer screening.
    Volk RJ; Linder SK; Kallen MA; Galliher JM; Spano MS; Mullen PD; Spann SJ
    Ann Fam Med; 2013; 11(1):67-74. PubMed ID: 23319508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen screening: An update of physician beliefs and practices.
    Hall IJ; Rim SH; Massetti GM; Thomas CC; Li J; Richardson LC
    Prev Med; 2017 Oct; 103():66-69. PubMed ID: 28793236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part I: Framing the debate.
    Barry MJ; Fleming C; Coley CM; Wasson JH; Fahs MC; Oesterling JE
    Urology; 1995 Jul; 46(1):2-13. PubMed ID: 7541583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.